Onco Wiki / Indication

Carcinome de cellules squameuses et de la vulve · ligne 1 · Aucune

Vue déterministe de l'entité source de la LJAM. L'autorité clinique demeure avec les ID de la source cités et l'état d'approbation de l ́examinateur.

Contenu clinique provisoire : il ne s'agit pas d'une ordonnance. Un oncologue doit vérifier les sources originales, l'applicabilité et le statut de révision.

Source YAML: dossier complet

Ligne thérapeutique1
Voielocal_therapy
Régime liéNone
IDIND-VULVAR-VAGINAL-SCC-1L-WLE-SLNB
TypeIndication
Étatreviewed 2026-07-11 | pending_clinical_signoff
MaladiesDIS-VULVAR-VAGINAL-SCC
SourcesSRC-GROINSS-V-VANDERZEE-2008 SRC-NCCN-CERVICAL-2025

Notes

STUB pending clinical co-lead signoff (CHARTER §6.1; dev-mode-exempted per CHARTER §8.3 — draft content only, NOT published/verified clinical advice). Surgical management is described in prose (stage_requirements / rationale) rather than via the `phases:` + `surgery_id` mechanism (KNOWLEDGE_SCHEMA_SPECIFICATION §17, as demonstrated by IND-MENINGIOMA-1L-RESECTION-RT) because no Surgery/procedure entity for vulvar wide local excision or inguinal sentinel lymph node biopsy exists yet under knowledge_base/hosted/content/procedures/ — authoring one is out of scope for this pass (flagged in the disease-file proposal notes as an open gap). Adjuvant RT for high-risk features (positive/close margins, positive groin nodes) is not modeled as a separate Indication in this pass — open gap.

Utilisé par

Algorithmes

Maladie